BrightPath Biotherapeutics Co., Ltd.
4594.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥7,797,385 | ¥4,766,669 | ¥3,865,834 | ¥3,895,003 |
| - Cash | ¥1,252,592 | ¥900,980 | ¥810,470 | ¥1,260,968 |
| + Debt | ¥0 | ¥0 | ¥25,000 | ¥162,500 |
| Enterprise Value | ¥6,544,793 | ¥3,865,689 | ¥3,080,364 | ¥2,796,535 |
| Revenue | ¥0 | ¥33 | ¥1,044 | ¥33 |
| % Growth | -100% | -96.8% | 3,063.6% | – |
| Gross Profit | ¥0 | ¥25 | ¥1,034 | ¥25 |
| % Margin | – | 75.8% | 99% | 75.8% |
| EBITDA | -¥220,263 | -¥241,264 | -¥335,589 | -¥275,873 |
| % Margin | – | -731,103% | -32,144.5% | -835,978.8% |
| Net Income | -¥220,868 | -¥241,869 | -¥336,064 | -¥276,349 |
| % Margin | – | -732,936.4% | -32,190% | -837,421.2% |
| EPS Diluted | -1.98 | -2.59 | -3.82 | -3.19 |
| % Growth | 23.6% | 32.2% | -19.7% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |